Characterization of adenosine receptors in the human bladder carcinoma T24 cell line

European Journal of Pharmacology

Volumn 536, Issue 1-2, 2006, Pages 28-37

  Phelps, P Tara ^a   Anthes, John C ^a   Correll, Craig C ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

5 N Ethylcarboxamidoadenosine; Adenosine A2B receptor; cAMP; Fluorometric imaging plate reader; Reverse transcriptase polymerase chain reaction; T24 cell line

Indexed keywords

1,3 DIETHYL 8 PHENYLXANTHINE; 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 8 (3 CHLOROSTYRYL)CAFFEINE; 8 [4 [((4 CYANO[2,6]PHENYL)CARBAMOYLMETHYL)OXY]PHENYL] 1,3 DI(N PROPYL)XANTHINE; ADENOSINE 5' (N CYCLOPROPYLCARBOXAMIDE); ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ALLOXAZINE; CALCIUM ION; CYCLIC AMP; INTERLEUKIN 8; N (7ACETYLPHENYL) 2 [4 (2,3,6,7 TETRAHYDRO 2,6 DIOXO 1,3 DIPROLYL 1H PURIN 8 YL)PHENOXY]ACETAMIDE; THEOPHYLLINE; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CARCINOMA; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG POTENCY; DRUG SELECTIVITY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOSINE; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); CALCIUM; CELL LINE, TUMOR; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-8; INTRACELLULAR FLUID; PROTEIN ISOFORMS; PURINES; RECEPTORS, PURINERGIC P1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; URINARY BLADDER NEOPLASMS; XANTHINES;

EID: 33645883843     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.02.046     Document Type: Article

References (50)

1. 3 receptors in rat brain. Mol. Pharmacol. 48 (1995) 1038-1045
2. Alexander, S.P.H., Losinski, A., Kendall, D., Hill, S.J., 1994. A comparison of A2 adenosine receptor stimulated cyclic AMP generation in cerebral cortex and relaxation of precontracted aorta.
3. 2B adenosine receptor expressed in Chinese hamster ovary (CHO.A2B4) cells. Br. J. Pharmacol. 119 (1996) 1286-1290
4. 2A-receptor gene-deficient mice. Biochem. J 354 (2001) 123-130
5. Birder L.A., Barrick S.R., Roppolo J.R., Kanai A.J., de Groat W.C., Kiss S., and Buffington C.A. Feline interstitial cystitis results in mechanical hypersensitivity and altered ATP release from bladder urothelium. Am. J. Physiol. Renal Physiol. 285 (2003) F423-F429
6. Bruns R.F., Daly J.W., and Pugeley T.A. Characterization of the A2 receptor labeled by [3H]-NECA in rat striatal membranes. Mol. Pharmacol. 29 (1986) 331-346
7. Burnstock. A basis for distinguishing two types of purinergic receptors. In: Bolis L., and Straub R.W. (Eds). Cell and Membrane Receptors For Drugs: A Multidisciplinary Approach (1978), Raven Press, New York 107-118
8. Burnstock. Purine-mediated signaling in pain and visceral perception. Trends Pharmacol. Sci. 22 (2001) 182-188
9. Cronstein B.N. Adenosine, an endogenous anti-inflammatory agent. J. Appl. Physiol. 76 (1994) 5-13
10. Cronstein B.N. A novel approach to the development of anti-inflammatory agents: adenosine release at inflamed sites. J. Investig. Med. 43 (1995) 50-57
11. Curhan G.C., Speizer F.E., Hunter D.J., Curhan S.G., and Stampfer M.J. Epidemiology of interstitial cystitis: a population based study. J. Urol. 161 (1999) 549-552
12. Dickenson J., and Hill S. Involvement of G-protein βγ subunits in coupling the adenosine A1 receptor phospholipase C in transfected CHO cells. Eur. J. Pharmacol. 355 (1998) 85-93
13. Dux D., Fastborn J., Ungerstedt U., Rudolphi K., and Fredholm B.B. Protective effect of adenosine and a novel xanthine derivate propentofylline on the cell damage after bilateral carotid occlusion in the gerbil hippocampus. Brain Res. 516 (1990) 248-256
14. Englert M., Quitterer U., and Klotz K.-N. Effector coupling of stably transfected human A3 adenosine receptors in CHO cells. Biochem. Pharmacol. 64 (2002) 61-65
15. 2 receptor subtypes. Mol. Pharmacol. 43 (1993) 909-914
16. 2B receptors evoke interleukin-8 secretion in human mast cells. J. Clin. Invest. 96 (1995) 1979-1986
17. 2B receptors. Biochem. Pharmacol. 55 (1998) 627-633
18. 1 via a cholera toxin-sensitive mechanism in human erythroleukemia cells. Mol. Pharmacol. 45 (1994) 1162-1167
19. Feoktistov I., Ryzhov S., Goldstein A.E., and Biaggioni I. Mast cell-mediated stimulation of angiogenesis. Mol. Med. 92 (2003) 485-492
20. Fredholm B.B., Ijzerman A.P., Jacobson K.A., Klotz K.-N., and Linden J. International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53 (2001) 527-552
21. Fredholm B.B., Irenius E., Kull B., and Schulte G. Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in chinese hamster ovary cells. Biochem. Pharmacol. 61 (2001) 443-448
22. Fry C.,H., Ikeda Y., Harvey R., Wu C., and Sui G.-P. Control of bladder function by peripheral nerves: avenues for novel drug targets. J. Urol. 63 (2004) 24-31
23. Hagberg H., Andersson P., Lacarewicz J., Jacobson I., Butcher S., and Sandberg M. Extracellular adenosine, inosine, hypoxanthine, and xanthine in relation to tissue nucleotides and purines in rat striatum during transient ischemia. J. Neurochem. 49 (1987) 227-331
24. 3 receptors. FEBS 336 (1993) 57-60
25. Johansson B., Halldner L., Dunwiddie T.V., Masino S.A., Poelchen W., Gimenez-Llort L., Escorihuela R.M., Fernandez-Teruel A., Wiesenfeld-Hallin Z., Xu X.J., Hardemark, et al. Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc. Natl. Acad. Sci. 98 (2001) 9407-9412
26. Keay S.K., Szekely Z., Conrads T.P., Veenstra T.D., Barchi J.J., Zhang C.-O., Koch K.R., and Michejda C.J. An antiproliferative factor from interstitial cystitis patients is a frizzled 8 protein-related sialoglycopeptide. Proc. Natl. Acad. Sci. 101 (2004) 11803-11808
27. 2B adenosine receptors. J. Med. Chem. 443 (2000) 1165-1172
28. King J.A., Huddart H., and Staff W.G. Purinergic modulation of rat urinary bladder detrusor smooth muscle. Gen. Pharmacol. 29 (1997) 597-604
29. Klotz K.-N., Hessling J., Hegler J., Owman C., Kull B., Fredholm B.B., and Lohse M.J. Comparative pharmacology of human adenosine receptor subtypes-characterization of stably transfected receptors in CHO cells. Naunyn-Schmiedebergs Arch. Pharmacol. 357 (1998) 1-9
30. q in human embryonic kidney 293 cells and HMC-1 mast cells. Mol. Pharamcol. 56 (1999) 705-713
31. Liu X.J., and Salter M.W. Purines and pain mechanisms: recent developments. Curr. Opin. Investig. Drugs. 6 (2005) 65-75
32. Lupica C.R., Cass W.A., Zahniser N.R., and Dunwiddie T.V. Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiologoy, cAMP formation and dopamine release in rat hippocampus and striatum. J. Pharmacol. Exp. Ther. 252 (1990) 1134-1141
33. 2B receptor. Biochem. Pharmacol. 64 (2002) 317-325
34. Merighi S., Varani K., Gessi S., Cattabriga E., Iannota V., Ulouglu C., Leung E., and Borea P.A. Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line. Eur. J. Pharmacol. 134 (2001) 1215-1226
35. 2B adenosine receptors. Br. J. Pharmacol. 122 (1997) 1075-1088
36. Mumtaz F.H., Khan M.A., Thompson C.S., Morgan R.J., and Mikhailidis D.P. Nitric oxide in the lower urinary tract: physiological and pathological implications. BJU Int. 85 (2000) 567-578
37. Nicholls J., Hourani S.M.O., and Kitchen I. Characterization of P1-purinoceptors on rat duodenum and urinary bladder. Br. J. Pharmacol. 105 (1992) 639-642
38. Ohta A., and Sitkovsky M. Role of G-protein coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414 (2001) 916-920
39. 2B receptor function assessed by Fluo-3-AM fluorometry and microphysiometry. Br. J. Pharmacol. 138 (2003) 671-677
40. 2B adenosine receptors. Br. J. Pharmacol. 129 (2000) 243-250
41. Peters K.M., Diokino A.C., and Steinert B.W. Preliminary study on urinary cytokine levels in interstitial cystitis: does intravesical bacille Calmette-Guerin treat interstitial cystitis by altering the immune profile in the bladder?. Urology 54 (1999) 450-453
42. 2A receptor gene. J. Neurochem. 66 (1996) 362-368
43. 2C receptors in CHO-K1 cells Br. J. Pharmacol. 128 (1999) 13-20
44. Puffinbarger N.K., Hansen K.R., Resta R., Laurent A.B., Knudsen T.B., Madara J.L., and Thompson L.F. Production and characterization of multiple antigenic peptide antibodies to the adenosine A2b receptor. Mol. Pharmacol. 47 (1995) 1126-1132
45. Ralevic V., and Burnstock G. Receptors for purines and pyrimidines. Pharmacol. Rev. 50 (1998) 413-492
46. Ramkumar V., Stiles G.L., Beaven M.A., and Ali H. The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J. Biol. Chem. 268 (1983) 16887-16890
47. Salvatore C.A., Jacobson M.A., Taylor H.E., Linden J., and Johnson R.G. Molecular cloning and characterization of the human A3 adenosine receptor. Proc. Natl. Acad. Sci. 90 (1993) 10365-10369
48. Sawyork J. Adenosine receptor activation and nociception. Eur. J. Pharmacol. 317 (1998) 1-11
49. Sun Y., Keay S., DeDeyne P., and Chai T.C. Augmented stretch activated adenosine triphosphate release from bladder uroepithelial cells in patients with interstitial cystitis. J. Urol. 166 (2001) 1951-1956
50. 2B adenosine receptors. Curr. Top. Med. Chem. 3 (2003) 427-443